Application 210455
- Type
- NDA
- Sponsor
- JANSSEN PRODS
Application Products#
| Product | Drug | Ingredient | Form | Strength | Reference drug | Reference standard |
|---|---|---|---|---|---|---|
| 001 | SYMTUZA | COBICISTAT; DARUNAVIR; EMTRICITABINE; TENOFOVIR ALAFENAMIDE FUMARATE | TABLET;ORAL | 150MG;800MG;200MG;EQ 10MG BASE | Yes | Yes |
Orange Book products#
| Application-product | Trade name | Ingredient | Strength | Dosage form / route | TE codes | RLD / RS | Approval date |
|---|---|---|---|---|---|---|---|
| N210455-001 | SYMTUZA | COBICISTAT; DARUNAVIR; EMTRICITABINE; TENOFOVIR ALAFENAMIDE FUMARATE | 150MG;800MG;200MG;EQ 10MG BASE | TABLET / ORAL | RLD, RS | 2018-07-17 |
Orange Book patents#
| Application-product | Patent | Expiration | Use code | Coverage / status | Submission date |
|---|---|---|---|---|---|
| N210455-001 | 7700645 | 2026-12-26 | Drug substance, Drug product | 2018-08-15 | |
| N210455-001 | 8148374 | 2029-09-03 | U-2353 | Drug substance, Drug product | 2018-08-15 |
| N210455-001 | 8148374 | 2029-09-03 | U-2364 | Drug substance, Drug product | 2018-08-15 |
| N210455-001 | 8148374 | 2029-09-03 | U-2365 | Drug substance, Drug product | 2018-08-15 |
| N210455-001 | 8148374 | 2029-09-03 | U-2766 | Drug substance, Drug product | 2018-08-15 |
| N210455-001 | 8148374 | 2029-09-03 | U-2767 | Drug substance, Drug product | 2018-08-15 |
| N210455-001 | 8148374 | 2029-09-03 | U-2768 | Drug substance, Drug product | 2018-08-15 |
| N210455-001 | 8754065 | 2032-08-15 | U-2352 | Drug substance, Drug product | 2018-08-15 |
| N210455-001 | 8754065 | 2032-08-15 | U-2765 | Drug substance, Drug product | 2018-08-15 |
| N210455-001 | 9296769 | 2032-08-15 | U-2352 | Drug substance, Drug product | 2018-08-15 |
| N210455-001 | 9296769 | 2032-08-15 | U-2765 | Drug substance, Drug product | 2018-08-15 |
| N210455-001 | 10039718 | 2032-10-06 | Drug product | 2018-09-05 | |
| N210455-001 | 10786518 | 2038-07-19 | U-2978 | 2020-10-28 |
Observed Orange Book product history#
Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
| Captured | Edition | Application-product | Trade name | Strength | Dosage form / route | Product TE source text | RLD / RS | Approval date | Source SHA-256 |
|---|---|---|---|---|---|---|---|---|---|
| 2026-02-19 14:30 UTC | 2026-02 | N210455-001 | SYMTUZA | 150MG;800MG;200MG;EQ 10MG BASE | TABLET / ORAL | RLD, RS | 2018-07-17 | 011fe1cb6892… | |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N210455-001 | SYMTUZA | 150MG;800MG;200MG;EQ 10MG BASE | TABLET / ORAL | RLD, RS | 2018-07-17 | 31067a03dcf5… | |
| 2025-08-23 18:47 UTC | 2025-08 | N210455-001 | SYMTUZA | 150MG;800MG;200MG;EQ 10MG BASE | TABLET / ORAL | RLD, RS | 2018-07-17 | 6a471c1ec25d… | |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | N210455-001 | SYMTUZA | 150MG;800MG;200MG;EQ 10MG BASE | TABLET / ORAL | RLD, RS | 2018-07-17 | fd3edfee7708… | |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | N210455-001 | SYMTUZA | 150MG;800MG;200MG;EQ 10MG BASE | TABLET / ORAL | RLD, RS | 2018-07-17 | b8a1b40f171c… | |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | N210455-001 | SYMTUZA | 150MG;800MG;200MG;EQ 10MG BASE | TABLET / ORAL | RLD, RS | 2018-07-17 | 03ed91905a0d… | |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | N210455-001 | SYMTUZA | 150MG;800MG;200MG;EQ 10MG BASE | TABLET / ORAL | RLD, RS | 2018-07-17 | 2680178bc6a6… | |
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | N210455-001 | SYMTUZA | 150MG;800MG;200MG;EQ 10MG BASE | TABLET / ORAL | RLD, RS | 2018-07-17 | 5bbf6a4d5a75… | |
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | N210455-001 | SYMTUZA | 150MG;800MG;200MG;EQ 10MG BASE | TABLET / ORAL | RLD, RS | 2018-07-17 | d8e5a09893c0… | |
| 2024-10-29 15:01 UTC | 2024-10 | N210455-001 | SYMTUZA | 150MG;800MG;200MG;EQ 10MG BASE | TABLET / ORAL | RLD, RS | 2018-07-17 | d06236e962d9… | |
| 2024-08-13 05:28 UTC · 3 captures of this ZIP | 2024-08 | N210455-001 | SYMTUZA | 150MG;800MG;200MG;EQ 10MG BASE | TABLET / ORAL | RLD, RS | 2018-07-17 | 79d66fd596c7… | |
| 2024-07-13 05:37 UTC · 2 captures of this ZIP | 2024-07 | N210455-001 | SYMTUZA | 150MG;800MG;200MG;EQ 10MG BASE | TABLET / ORAL | RLD, RS | 2018-07-17 | 301d65b070ca… | |
| 2024-06-18 03:08 UTC · 5 captures of this ZIP | 2024-06 | N210455-001 | SYMTUZA | 150MG;800MG;200MG;EQ 10MG BASE | TABLET / ORAL | RLD, RS | 2018-07-17 | 1e350fbaab3a… | |
| 2024-05-31 18:47 UTC | 2024-05 | N210455-001 | SYMTUZA | 150MG;800MG;200MG;EQ 10MG BASE | TABLET / ORAL | RLD, RS | 2018-07-17 | 8072bd15b7f6… | |
| 2022-06-29 02:47 UTC · 2 captures of this ZIP | 2022-06 | N210455-001 | SYMTUZA | 150MG;800MG;200MG;EQ 10MG BASE | TABLET / ORAL | RLD, RS | 2018-07-17 | 5c6f7cd8ea54… | |
| 2022-04-08 23:34 UTC | 2022-04 | N210455-001 | SYMTUZA | 150MG;800MG;200MG;EQ 10MG BASE | TABLET / ORAL | RLD, RS | 2018-07-17 | 5d02ea3f76ae… | |
| 2022-04-04 05:41 UTC | 2022-04 | N210455-001 | SYMTUZA | 150MG;800MG;200MG;EQ 10MG BASE | TABLET / ORAL | RLD, RS | 2018-07-17 | 4b0b4de00fa7… | |
| 2019-12-13 00:20 UTC | 2019-12 | N210455-001 | SYMTUZA | 150MG;800MG;200MG;EQ 10MG BASE | TABLET / ORAL | RLD, RS | 2018-07-17 | 74a2ff9319b5… | |
| 2022-03-09 01:35 UTC | 2022-03 | N210455-001 | SYMTUZA | 150MG;800MG;200MG;EQ 10MG BASE | TABLET / ORAL | RLD, RS | 2018-07-17 | bb7c543d1eb4… | |
| 2021-12-28 21:50 UTC | 2021-12 | N210455-001 | SYMTUZA | 150MG;800MG;200MG;EQ 10MG BASE | TABLET / ORAL | RLD, RS | 2018-07-17 | 782e0a99824c… | |
| 2021-05-05 16:15 UTC · 3 captures of this ZIP | 2021-05 | N210455-001 | SYMTUZA | 150MG;800MG;200MG;EQ 10MG BASE | TABLET / ORAL | RLD, RS | 2018-07-17 | 87673890dc5c… | |
| 2021-03-12 10:30 UTC | 2021-03 | N210455-001 | SYMTUZA | 150MG;800MG;200MG;EQ 10MG BASE | TABLET / ORAL | RLD, RS | 2018-07-17 | 5aa47cf7b7d7… | |
| 2020-12-22 03:56 UTC | 2020-12 | N210455-001 | SYMTUZA | 150MG;800MG;200MG;EQ 10MG BASE | TABLET / ORAL | RLD, RS | 2018-07-17 | 8869cabd3fbd… | |
| 2020-11-12 02:37 UTC | 2020-11 | N210455-001 | SYMTUZA | 150MG;800MG;200MG;EQ 10MG BASE | TABLET / ORAL | RLD, RS | 2018-07-17 | c0c555d07b60… | |
| 2019-12-14 00:12 UTC | 2019-12 | N210455-001 | SYMTUZA | 150MG;800MG;200MG;EQ 10MG BASE | TABLET / ORAL | RLD, RS | 2018-07-17 | 3f01610625f2… | |
| 2019-09-15 20:21 UTC | 2019-09 | N210455-001 | SYMTUZA | 150MG;EQ 800MG BASE;200MG;EQ 10MG BASE | TABLET / ORAL | RLD, RS | 2018-07-17 | b00525d2431f… | |
| 2019-07-19 19:46 UTC | 2019-07 | N210455-001 | SYMTUZA | 150MG;EQ 800MG BASE;200MG;EQ 10MG BASE | TABLET / ORAL | RLD, RS | 2018-07-17 | ea99ee380514… | |
| 2024-03-16 18:09 UTC · 4 captures of this ZIP | 2024-03 | N210455-001 | SYMTUZA | 150MG;800MG;200MG;EQ 10MG BASE | TABLET / ORAL | RLD, RS | 2018-07-17 | 6a51e52b5d6a… | |
| 2024-02-18 07:12 UTC | 2024-02 | N210455-001 | SYMTUZA | 150MG;800MG;200MG;EQ 10MG BASE | TABLET / ORAL | RLD, RS | 2018-07-17 | 1c564ffb4f44… | |
| 2023-12-20 04:57 UTC | 2023-12 | N210455-001 | SYMTUZA | 150MG;800MG;200MG;EQ 10MG BASE | TABLET / ORAL | RLD, RS | 2018-07-17 | ea1830bbd6c7… | |
| 2023-11-28 05:40 UTC · 2 captures of this ZIP | 2023-11 | N210455-001 | SYMTUZA | 150MG;800MG;200MG;EQ 10MG BASE | TABLET / ORAL | RLD, RS | 2018-07-17 | a72a2bbeb626… | |
| 2023-10-25 00:34 UTC · 2 captures of this ZIP | 2023-10 | N210455-001 | SYMTUZA | 150MG;800MG;200MG;EQ 10MG BASE | TABLET / ORAL | RLD, RS | 2018-07-17 | 9b2671bbb829… | |
| 2023-07-15 15:27 UTC · 2 captures of this ZIP | 2023-07 | N210455-001 | SYMTUZA | 150MG;800MG;200MG;EQ 10MG BASE | TABLET / ORAL | RLD, RS | 2018-07-17 | a67488948f0b… | |
| 2023-06-13 01:57 UTC · 3 captures of this ZIP | 2023-06 | N210455-001 | SYMTUZA | 150MG;800MG;200MG;EQ 10MG BASE | TABLET / ORAL | RLD, RS | 2018-07-17 | 3f0d92c62455… | |
| 2023-05-13 08:27 UTC | 2023-05 | N210455-001 | SYMTUZA | 150MG;800MG;200MG;EQ 10MG BASE | TABLET / ORAL | RLD, RS | 2018-07-17 | 053a50430f4f… | |
| 2023-01-26 05:58 UTC | 2023-01 | N210455-001 | SYMTUZA | 150MG;800MG;200MG;EQ 10MG BASE | TABLET / ORAL | RLD, RS | 2018-07-17 | 3bdfa0b2c4d7… | |
| 2022-11-12 20:34 UTC · 5 captures of this ZIP | 2022-11 | N210455-001 | SYMTUZA | 150MG;800MG;200MG;EQ 10MG BASE | TABLET / ORAL | RLD, RS | 2018-07-17 | 3a93d1ddd44b… | |
| 2022-10-28 04:53 UTC | 2022-10 | N210455-001 | SYMTUZA | 150MG;800MG;200MG;EQ 10MG BASE | TABLET / ORAL | RLD, RS | 2018-07-17 | f41ea6bd6efb… | |
| 2022-09-29 23:25 UTC | 2022-09 | N210455-001 | SYMTUZA | 150MG;800MG;200MG;EQ 10MG BASE | TABLET / ORAL | RLD, RS | 2018-07-17 | e64feba35796… | |
| 2022-07-09 03:26 UTC · 3 captures of this ZIP | 2022-07 | N210455-001 | SYMTUZA | 150MG;800MG;200MG;EQ 10MG BASE | TABLET / ORAL | RLD, RS | 2018-07-17 | cb3db0bc1861… |
Observed Orange Book patent history#
| Captured | Edition | Application-product | Patent | Expiration | Use code | Coverage / status | Submission date | Source SHA-256 |
|---|---|---|---|---|---|---|---|---|
| 2026-02-19 14:30 UTC | 2026-02 | N210455-001 | 7700645 | 2026-12-26 | Drug substance, Drug product | 2018-08-15 | 011fe1cb6892… | |
| 2026-02-19 14:30 UTC | 2026-02 | N210455-001 | 8148374 | 2029-09-03 | U-2353 | Drug substance, Drug product | 2018-08-15 | 011fe1cb6892… |
| 2026-02-19 14:30 UTC | 2026-02 | N210455-001 | 8148374 | 2029-09-03 | U-2767 | Drug substance, Drug product | 2018-08-15 | 011fe1cb6892… |
| 2026-02-19 14:30 UTC | 2026-02 | N210455-001 | 8148374 | 2029-09-03 | U-2768 | Drug substance, Drug product | 2018-08-15 | 011fe1cb6892… |
| 2026-02-19 14:30 UTC | 2026-02 | N210455-001 | 8148374 | 2029-09-03 | U-2766 | Drug substance, Drug product | 2018-08-15 | 011fe1cb6892… |
| 2026-02-19 14:30 UTC | 2026-02 | N210455-001 | 8148374 | 2029-09-03 | U-2364 | Drug substance, Drug product | 2018-08-15 | 011fe1cb6892… |
| 2026-02-19 14:30 UTC | 2026-02 | N210455-001 | 8148374 | 2029-09-03 | U-2365 | Drug substance, Drug product | 2018-08-15 | 011fe1cb6892… |
| 2026-02-19 14:30 UTC | 2026-02 | N210455-001 | 8754065 | 2032-08-15 | U-2352 | Drug substance, Drug product | 2018-08-15 | 011fe1cb6892… |
| 2026-02-19 14:30 UTC | 2026-02 | N210455-001 | 8754065 | 2032-08-15 | U-2765 | Drug substance, Drug product | 2018-08-15 | 011fe1cb6892… |
| 2026-02-19 14:30 UTC | 2026-02 | N210455-001 | 9296769 | 2032-08-15 | U-2352 | Drug substance, Drug product | 2018-08-15 | 011fe1cb6892… |
| 2026-02-19 14:30 UTC | 2026-02 | N210455-001 | 9296769 | 2032-08-15 | U-2765 | Drug substance, Drug product | 2018-08-15 | 011fe1cb6892… |
| 2026-02-19 14:30 UTC | 2026-02 | N210455-001 | 10039718 | 2032-10-06 | Drug product | 2018-09-05 | 011fe1cb6892… | |
| 2026-02-19 14:30 UTC | 2026-02 | N210455-001 | 10786518 | 2038-07-19 | U-2978 | 2020-10-28 | 011fe1cb6892… | |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N210455-001 | 7390791 | 2025-04-17 | Drug substance, Drug product | 2018-08-15 | 31067a03dcf5… | |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N210455-001 | 7700645 | 2026-12-26 | Drug substance, Drug product | 2018-08-15 | 31067a03dcf5… | |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N210455-001 | 8148374 | 2029-09-03 | U-2353 | Drug substance, Drug product | 2018-08-15 | 31067a03dcf5… |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N210455-001 | 8148374 | 2029-09-03 | U-2767 | Drug substance, Drug product | 2018-08-15 | 31067a03dcf5… |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N210455-001 | 8148374 | 2029-09-03 | U-2768 | Drug substance, Drug product | 2018-08-15 | 31067a03dcf5… |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N210455-001 | 8148374 | 2029-09-03 | U-2766 | Drug substance, Drug product | 2018-08-15 | 31067a03dcf5… |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N210455-001 | 8148374 | 2029-09-03 | U-2364 | Drug substance, Drug product | 2018-08-15 | 31067a03dcf5… |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N210455-001 | 8148374 | 2029-09-03 | U-2365 | Drug substance, Drug product | 2018-08-15 | 31067a03dcf5… |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N210455-001 | 8754065 | 2032-08-15 | U-2352 | Drug substance, Drug product | 2018-08-15 | 31067a03dcf5… |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N210455-001 | 8754065 | 2032-08-15 | U-2765 | Drug substance, Drug product | 2018-08-15 | 31067a03dcf5… |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N210455-001 | 9296769 | 2032-08-15 | U-2352 | Drug substance, Drug product | 2018-08-15 | 31067a03dcf5… |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N210455-001 | 9296769 | 2032-08-15 | U-2765 | Drug substance, Drug product | 2018-08-15 | 31067a03dcf5… |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N210455-001 | 10039718 | 2032-10-06 | Drug product | 2018-09-05 | 31067a03dcf5… | |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N210455-001 | 10786518 | 2038-07-19 | U-2978 | 2020-10-28 | 31067a03dcf5… | |
| 2025-08-23 18:47 UTC | 2025-08 | N210455-001 | 7390791 | 2025-04-17 | Drug substance, Drug product | 2018-08-15 | 6a471c1ec25d… | |
| 2025-08-23 18:47 UTC | 2025-08 | N210455-001 | 7700645 | 2026-12-26 | Drug substance, Drug product | 2018-08-15 | 6a471c1ec25d… | |
| 2025-08-23 18:47 UTC | 2025-08 | N210455-001 | 8148374 | 2029-09-03 | U-2353 | Drug substance, Drug product | 2018-08-15 | 6a471c1ec25d… |
| 2025-08-23 18:47 UTC | 2025-08 | N210455-001 | 8148374 | 2029-09-03 | U-2767 | Drug substance, Drug product | 2018-08-15 | 6a471c1ec25d… |
| 2025-08-23 18:47 UTC | 2025-08 | N210455-001 | 8148374 | 2029-09-03 | U-2768 | Drug substance, Drug product | 2018-08-15 | 6a471c1ec25d… |
| 2025-08-23 18:47 UTC | 2025-08 | N210455-001 | 8148374 | 2029-09-03 | U-2766 | Drug substance, Drug product | 2018-08-15 | 6a471c1ec25d… |
| 2025-08-23 18:47 UTC | 2025-08 | N210455-001 | 8148374 | 2029-09-03 | U-2364 | Drug substance, Drug product | 2018-08-15 | 6a471c1ec25d… |
| 2025-08-23 18:47 UTC | 2025-08 | N210455-001 | 8148374 | 2029-09-03 | U-2365 | Drug substance, Drug product | 2018-08-15 | 6a471c1ec25d… |
| 2025-08-23 18:47 UTC | 2025-08 | N210455-001 | 8754065 | 2032-08-15 | U-2352 | Drug substance, Drug product | 2018-08-15 | 6a471c1ec25d… |
| 2025-08-23 18:47 UTC | 2025-08 | N210455-001 | 8754065 | 2032-08-15 | U-2765 | Drug substance, Drug product | 2018-08-15 | 6a471c1ec25d… |
| 2025-08-23 18:47 UTC | 2025-08 | N210455-001 | 9296769 | 2032-08-15 | U-2352 | Drug substance, Drug product | 2018-08-15 | 6a471c1ec25d… |
| 2025-08-23 18:47 UTC | 2025-08 | N210455-001 | 9296769 | 2032-08-15 | U-2765 | Drug substance, Drug product | 2018-08-15 | 6a471c1ec25d… |
| 2025-08-23 18:47 UTC | 2025-08 | N210455-001 | 10039718 | 2032-10-06 | Drug product | 2018-09-05 | 6a471c1ec25d… |
Observed Orange Book exclusivity history#
| Captured | Edition | Application-product | Exclusivity code | Expiration | Source SHA-256 |
|---|---|---|---|---|---|
| 2019-12-13 00:20 UTC | 2019-12 | N210455-001 | NC | 2020-07-17 | 74a2ff9319b5… |
| 2019-12-13 00:20 UTC | 2019-12 | N210455-001 | NCE | 2020-11-05 | 74a2ff9319b5… |
| 2021-12-28 21:50 UTC | 2021-12 | N210455-001 | NC | 2021-07-17 | 782e0a99824c… |
| 2021-05-05 16:15 UTC · 3 captures of this ZIP | 2021-05 | N210455-001 | NC | 2021-07-17 | 87673890dc5c… |
| 2021-03-12 10:30 UTC | 2021-03 | N210455-001 | NC | 2021-07-17 | 5aa47cf7b7d7… |
| 2020-12-22 03:56 UTC | 2020-12 | N210455-001 | NCE | 2020-11-05 | 8869cabd3fbd… |
| 2020-12-22 03:56 UTC | 2020-12 | N210455-001 | NC | 2021-07-17 | 8869cabd3fbd… |
| 2020-11-12 02:37 UTC | 2020-11 | N210455-001 | NCE | 2020-11-05 | c0c555d07b60… |
| 2020-11-12 02:37 UTC | 2020-11 | N210455-001 | NC | 2021-07-17 | c0c555d07b60… |
| 2019-12-14 00:12 UTC | 2019-12 | N210455-001 | NC | 2020-07-17 | 3f01610625f2… |
| 2019-12-14 00:12 UTC | 2019-12 | N210455-001 | NCE | 2020-11-05 | 3f01610625f2… |
| 2019-09-15 20:21 UTC | 2019-09 | N210455-001 | NC | 2020-07-17 | b00525d2431f… |
| 2019-09-15 20:21 UTC | 2019-09 | N210455-001 | NCE | 2020-11-05 | b00525d2431f… |
| 2019-07-19 19:46 UTC | 2019-07 | N210455-001 | NC | 2020-07-17 | ea99ee380514… |
| 2019-07-19 19:46 UTC | 2019-07 | N210455-001 | NCE | 2020-11-05 | ea99ee380514… |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Symtuza | DARUNAVIR, COBICISTAT, EMTRICITABINE, AND TENOFOVIR ALAFENAMIDE | Janssen Products LP | 85a17d00-6b7c-41ea-a6b3-5ad924820dab | 2026-04-17 | Boxed warning, Warnings, Adverse reactions | 210455 NDA210455 59676-800 |
NDC Listings For This Application#
| NDC | Name | Nonproprietary name | Labeler | Marketing category | Status |
|---|---|---|---|---|---|
| 59676-800 | Symtuza | Darunavir, Cobicistat, Emtricitabine, and Tenofovir alafenamide | Janssen Products LP | NDA | Current |
| 59676-800 | Symtuza | Darunavir, Cobicistat, Emtricitabine, and Tenofovir alafenamide | Janssen Products LP | NDA | Current |
| 59676-800 | Symtuza | Darunavir, Cobicistat, Emtricitabine, and Tenofovir alafenamide | Janssen Products LP | NDA | Current |
| 59676-800 | Symtuza | Darunavir, Cobicistat, Emtricitabine, and Tenofovir alafenamide | Janssen Products LP | NDA | Current |
| 59676-800 | Symtuza | Darunavir, Cobicistat, Emtricitabine, and Tenofovir alafenamide | Janssen Products LP | NDA | Current |
| 59676-800 | Symtuza | Darunavir, Cobicistat, Emtricitabine, and Tenofovir alafenamide | Janssen Products LP | NDA | Current |
| 59676-800 | Symtuza | Darunavir, Cobicistat, Emtricitabine, and Tenofovir alafenamide | Janssen Products LP | NDA | Current |
| 59676-800 | Symtuza | Darunavir, Cobicistat, Emtricitabine, and Tenofovir alafenamide | Janssen Products LP | NDA | Current |
| 59676-800 | Symtuza | Darunavir, Cobicistat, Emtricitabine, and Tenofovir alafenamide | Janssen Products LP | NDA | Current |
| 59676-800 | Symtuza | Darunavir, Cobicistat, Emtricitabine, and Tenofovir alafenamide | Janssen Products LP | NDA | Current |
| 59676-800 | Symtuza | Darunavir, Cobicistat, Emtricitabine, and Tenofovir alafenamide | Janssen Products LP | NDA | Current |
Documents#
| Document | Submission type | Date |
|---|---|---|
| 73935 | SUPPL | 2023-04-03 |
| 73924 | SUPPL | 2023-04-03 |
| 72473 | SUPPL | 2022-10-26 |
| 72448 | SUPPL | 2022-10-24 |
| 70778 | SUPPL | 2022-04-18 |
| 70771 | SUPPL | 2022-04-15 |
| 68247 | SUPPL | 2021-08-02 |
| 68231 | SUPPL | 2021-07-30 |
| 69279 | SUPPL | 2021-06-29 |
| 67976 | SUPPL | 2021-06-29 |
| 65753 | SUPPL | 2020-12-28 |
| 65723 | SUPPL | 2020-12-23 |
| 62022 | SUPPL | 2020-03-04 |
| 62019 | SUPPL | 2020-03-04 |
| 58936 | SUPPL | 2019-06-04 |
| 58905 | SUPPL | 2019-05-31 |
| 57836 | SUPPL | 2019-02-28 |
| 57824 | SUPPL | 2019-02-27 |
| 57546 | SUPPL | 2019-02-13 |
| 57356 | SUPPL | 2019-01-28 |
| 56704 | ORIG | 2018-12-11 |
| 54955 | ORIG | 2018-07-24 |
| 54912 | ORIG | 2018-07-18 |
| 67067 | SUPPL | 1900-01-01 |
| 67066 | SUPPL | 1900-01-01 |
| 62936 | ORIG | 1900-01-01 |
| 62929 | SUPPL | 1900-01-01 |
| 62925 | SUPPL | 1900-01-01 |